Search
Publication
Risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
At the request of the European Commission’s Directorate-General for Health and Consumers, a rapid risk assessment has been prepared concerning the outbreak of E Coli in Germany.
Publication
Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
Publication
Outbreak of Shiga toxin-producing E. coli (STEC) in Germany, May 2011
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains capable of producing Shiga toxins, with the potential to cause severe enteric and systemic disease in humans.
Publication
Revised risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
An update of the initial rapid risk assessment on the outbreak of E. Coli in Germany, prepared at the request of the European Commission, first published on 27 May 2011.
Publication
Risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
Based on current evidence, it is not possible to confirm or exclude a causal relationship between detection of the new orthobunyavirus and the observed clinical symptoms in cattle and small livestock.
Publication
Joint risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
This updated rapid risk assessment was prepared jointly with the Robert Koch Institute (RKI), Germany, and the National Institute of Public Health and the Environment (RIVM), Netherlands.
Publication
Joint rapid risk assessment: Anthrax cases among injecting drug users, Germany, 22 June 2012
Following reports of two cases of anthrax among injecting drug users in Germany, ECDC and EMCDDA jointly prepared a rapid risk assessment.
Publication
Rapid risk assessment: Anthrax cases among injecting drug users - Germany, June-July 2012 - Update, 6 July 2012
This is an update to the joint rapid risk assessment published on 22 June 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to a third case in Berlin. It contains information updated up to the 6 July 2012.
Publication
Risk assessment: Anthrax cases among injecting drug users Germany, June-July 2012 - Update, 13 July 2012
This is an update to the joint rapid risk assessment published on 6 July 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to further cases in France and Denmark. It contains information updated up to the 13 July 2012.
Publication
Rapid risk assessment: Multi-country outbreak of Salmonella Stanley infections
Following an increase in the number of reported human infections with Salmonella entrica serovar Stanley in some EU countries, the European Commission requested a risk assessment from ECDC.